This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Enterobacter cancerogenus: NCBI 69218, [species]

Back to details

| ATCC 33241| ATCC 35317 [[Enterobacter taylorae Farmer et al. 1985]]| CCUG 18765 [[Enterobacter taylorae Farmer et al. 1985]]| CCUG 25231| CCUG 25589 [[Enterobacter taylorae Farmer et al. 1985]]| CDC 2126-81 [[Enterobacter taylorae Farmer et al. 1985]]| CDC Enteric Group 19| CFBP 4167| CIP 103787| DSM 17580| Enterobacter cancerogenus| Enterobacter cancerogenus (Urosevic 1966) Dickey and Zumoff 1988| Enterobacter taylorae| Enterobacter taylorae Farmer et al. 1985| Erwinia cancerogena| Erwinia cancerogena Urosevic 1966 (Approved Lists 1980)| ICMP 5706| JCM 3943 [[Enterobacter taylorae Farmer et al. 1985]]| LMG 2693| LMG:2693| NCPPB 2176| NCTC 12126 [[Enterobacter taylorae Farmer et al. 1985]]

  1. Infective endocarditis: Streptococcus gallolyticus subsp. gallolyticus is one of the leading causes of infective endocarditis, particularly in individuals with underlying heart conditions or predisposing factors such as damaged heart valves.

  2. Colorectal cancer: There is evidence to suggest an association between Streptococcus gallolyticus subsp. gallolyticus infection and colorectal cancer. Individuals with colorectal cancer have been found to have higher rates of colonization with this bacterium compared to healthy individuals.

  3. Bacteremia: Streptococcus gallolyticus subsp. gallolyticus can also cause bacteremia, which is the presence of bacteria in the bloodstream. Bacteremia caused by this bacterium is often associated with underlying gastrointestinal conditions, such as inflammatory bowel disease or colorectal cancer.

  4. Gastrointestinal infections: In rare cases, Streptococcus gallolyticus subsp. gallolyticus may cause gastrointestinal infections, including diarrhea and abdominal pain, particularly in individuals with compromised immune systems.

Other Sources for more information:

Legend

Enterobacter cancerogenus impacts on other bacteria of the same rank

R2SlopeTax NameParent Chart
0.3992348015308380.757705807685852Leclercia pneumoniaeParent Taxa
0.32064017653465270.6610990166664124Kosakonia cowaniiParent Taxa
0.27737843990325930.5343887805938721Pectobacterium carotovorumParent Taxa
0.27470806241035460.5840846300125122Enterobacter moriParent Taxa

Other bacteria of the same rank impacting Enterobacter cancerogenus

R2SlopeTax NameParent Chart

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]